Physician profile
Michael Joseph Everson
NPI 1841857562
$5,491.20
in general payments reported to CMS, 2019-2025
18 companies · $1,495 in 2025
The $1,495 reported for 2025 was more than what 91% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $106 · 2021: $539 · 2022: $931 · 2023: $894 · 2024: $587 · 2025: $1,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,825 · Gift: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,825.44 |
| Gift | $150.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,751.58 | 2019-2025 | Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity, Precision 1 |
| Biotissue Holdings INC. | $972.73 | 2025 | |
| Bausch & Lomb Americas INC. | $614.99 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $503.13 | 2020-2023 | |
| Rxsight INC | $307.22 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Johnson & Johnson Vision Care, INC. | $280.72 | 2019-2025 | Acuvue |
| Coopervision INC. | $185.13 | 2019-2023 | Onefit Contact Lens |
| Abbvie INC. | $170.68 | 2022-2025 | |
| Visionary Optics LLC | $150.50 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $122.39 | 2021 | |
| Glaukos Corporation | $122.28 | 2023-2025 | Istent Inject Trabecular Micro-Bypass System, Gts100-Glaukos Istent Trabecular Micro-Bypass Stent System, Istent Trabecular Micro-Bypass Stent System |
| Dompe US, INC. | $111.18 | 2024-2025 | Oxervate |
| Harrow Eye, LLC | $66.58 | 2025 | Triesence, Vevye |
| Sun Pharmaceutical Industries INC. | $39.82 | 2021-2023 | Cequa |
| Amgen INC. | $34.56 | 2025 | Tepezza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $25.69 | 2025 | Lensar Laser System |
| New World Medical,INC. | $18.45 | 2025 | Clearpath, Streamline, Kahook Dual Blade |
| Oyster Point Pharma, INC. | $13.57 | 2025 | Tyrvaya, Ryzumvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Everson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.